NCT01572454View on ClinicalTrials.gov

Comparison of Dexmedetomidine and Remifentanil Infusion During CABG

NACompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Coronary Artery Bypass GraftHypokalemiaCardiac ArrhythmiaDexmedetomidineRemifentanil
Interventions
DRUG

Dexmedetomidine infusion

Dexmedetomidine infusion 0.2 mcg/kg/hr during anesthetic induction 0.3 - 0.7 mcg/kg/hr during the surgery

DRUG

Remifentanil infusion

Remifentanil infusion 0.05 - 0.3 mcg/kg/min during the anesthetic induction and surgery

Trial Locations (1)

135-710

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Samsung Medical Center

OTHER

NCT01572454 - Comparison of Dexmedetomidine and Remifentanil Infusion During CABG | Biotech Hunter | Biotech Hunter